Information  X 
Enter a valid email address

IMI PLC (IMI)

  Print      Mail a friend

Monday 16 September, 2019

IMI PLC

Director/PDMR Shareholding

RNS Number : 4989M
IMI PLC
16 September 2019
 

16 September 2019

IMI PLC
(the "Company")

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them

This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Massimo Grassi

2.

Reason for the notification

a)

Position/status

Divisional Managing Director

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IMI plc

b)

LEI

2138002W9Q21PF751R30

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

  Identification code

Ordinary share

 
GB00BGLP8L22

b)

Nature of the transaction

Acquisition of shares as a result of the reinvestment of dividends awarded pursuant to participation in the IMI plc Employee Share Ownership Plan.

 c)

Price(s) and volume(s)

Price(s)

Volume(s)

£10.24

23

d)

Aggregated information

·      Aggregated volume

·      Price

N/A Single transaction

e)

Date of the transaction

13 September 2019

f)

Place of the transaction

London Stock Exchange Main Market (XLON)






For further information, please contact:

John O'Shea
Group Legal Director and Company Secretary
Telephone: 0121 717 3700


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHSFUFLMFUSELU

a d v e r t i s e m e n t